DE2531299A1 - L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung - Google Patents

L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung

Info

Publication number
DE2531299A1
DE2531299A1 DE19752531299 DE2531299A DE2531299A1 DE 2531299 A1 DE2531299 A1 DE 2531299A1 DE 19752531299 DE19752531299 DE 19752531299 DE 2531299 A DE2531299 A DE 2531299A DE 2531299 A1 DE2531299 A1 DE 2531299A1
Authority
DE
Germany
Prior art keywords
mmol
hydroxy
keto
content
lysine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19752531299
Other languages
German (de)
English (en)
Other versions
DE2531299C2 (enrdf_load_stackoverflow
Inventor
Hans Dr Dietl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius SE and Co KGaA
Original Assignee
Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG filed Critical Dr Eduard Fresenius Chemisch Pharmazeutische Industrie KG
Priority to DE19752531299 priority Critical patent/DE2531299A1/de
Priority to FR7620328A priority patent/FR2317919A1/fr
Publication of DE2531299A1 publication Critical patent/DE2531299A1/de
Application granted granted Critical
Publication of DE2531299C2 publication Critical patent/DE2531299C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE19752531299 1975-07-12 1975-07-12 L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung Granted DE2531299A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19752531299 DE2531299A1 (de) 1975-07-12 1975-07-12 L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung
FR7620328A FR2317919A1 (fr) 1975-07-12 1976-07-02 Melanges contenant des l-aminoacides et des hydroxy- et/ou ceto-acides, et leur utilisation therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752531299 DE2531299A1 (de) 1975-07-12 1975-07-12 L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung

Publications (2)

Publication Number Publication Date
DE2531299A1 true DE2531299A1 (de) 1977-01-13
DE2531299C2 DE2531299C2 (enrdf_load_stackoverflow) 1988-01-14

Family

ID=5951420

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752531299 Granted DE2531299A1 (de) 1975-07-12 1975-07-12 L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung

Country Status (2)

Country Link
DE (1) DE2531299A1 (enrdf_load_stackoverflow)
FR (1) FR2317919A1 (enrdf_load_stackoverflow)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936319A1 (de) * 1989-11-01 1991-05-02 Nephro Medica Pharma Phosphatbinder zur oralen verabreichung
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
CN101646358B (zh) * 2007-04-04 2013-05-29 赢创德固赛有限责任公司 含有a-酮酸的食品补充剂

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556593B1 (fr) * 1983-12-20 1987-01-02 Synthelabo Composition nutritive contenant de l'acide alpha-cetoisocaproique, de la leucine et des acides amines essentiels et non essentiels
DE19528524C2 (de) * 1995-08-03 1999-11-11 Hans Dietl Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
FR2880345A1 (fr) 2004-12-30 2006-07-07 Adisseo Ireland Ltd Synthese et applications de l'acide 2-oxo-4-methylthiobutyrique, ses tels et ses derives

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335215A1 (de) * 1972-07-13 1974-01-31 Mackenzie Walser Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE2335216A1 (de) * 1973-04-30 1974-11-21 Mackenzie Walser Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2335215A1 (de) * 1972-07-13 1974-01-31 Mackenzie Walser Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE2335216A1 (de) * 1973-04-30 1974-11-21 Mackenzie Walser Arzneimittel zur foerderung der proteinsynthese und zur unterdrueckung der harnstoffbildung
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936319A1 (de) * 1989-11-01 1991-05-02 Nephro Medica Pharma Phosphatbinder zur oralen verabreichung
DE3940052A1 (de) * 1989-12-04 1991-06-06 Nephro Medica Pharma Dialysier- und spuelloesung zur intraperitonealen verabreichung
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
CN101646358B (zh) * 2007-04-04 2013-05-29 赢创德固赛有限责任公司 含有a-酮酸的食品补充剂

Also Published As

Publication number Publication date
FR2317919B1 (enrdf_load_stackoverflow) 1978-11-03
FR2317919A1 (fr) 1977-02-11
DE2531299C2 (enrdf_load_stackoverflow) 1988-01-14

Similar Documents

Publication Publication Date Title
Hahn et al. Radioactive iron absorption by gastro-intestinal tract: influence of anemia, anoxia, and antecedent feeding distribution in growing dogs
DE3302008C2 (enrdf_load_stackoverflow)
DE68905387T2 (de) Aminosäure-Nahrungsmittelzusammensetzungen.
AT391980B (de) Verfahren zur erhoehung der gewichtszunahme von schweinen oder milchwirtschaftlich genutzten kuehen
DE2936236A1 (de) Aminosaeureloesung fuer die intravenoese ernaehrung
DE69002201T2 (de) Formulierung zur Behandlung der Nierenkrankheiten.
DE2556100A1 (de) Aminosaeurepraeparate fuer leberkranke patienten
DE3108079A1 (de) "nutriens-verbindungen und verfahren zu ihrer verabreichung"
Jones et al. Oral essential aminoacid and ketoacid supplements in children with chronic renal failure
Benchetrit et al. Ventilatory chemoreflex drive in the tortoise, Testudo horsfieldi
DE69331465T2 (de) Intravenöse lösung, die den protein - und wasserverlust im körper reduziert
DE2531299A1 (de) L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung
Unna et al. Effect of dietary protein on liver riboflavin levels and on inactivation of estradiol by liver.
Hughes Inter-relationships between egg shell quality, blood acid-base balance and dietary electrolytes
DE3421644C2 (enrdf_load_stackoverflow)
DE2946563C2 (de) Aminosäurelösung zur parenteralen Infusion
DE3781268T2 (de) Verwendung von wachstumshormonen zur stickstoffzurueckhaltung bei hypokalorischen bedingungen.
DE2531204C2 (de) L-Aminosäuregemische für die parenterale oder orale Ernährung
DE1667887C2 (de) Aminosäurelösung zur parenteralen Infusion
DE2642768C2 (enrdf_load_stackoverflow)
DE2636828C2 (enrdf_load_stackoverflow)
DE2530246A1 (de) L-aminosaeuregemische fuer parenterale oder orale anwendung
DE3414491A1 (de) L-aminosaeurengemische fuer die parenterale und orale anwendung bei nierenerkrankungen
DE2303463A1 (de) Emulsionen zur parenteralen ernaehrung und verfahren zu deren herstellung
Godin Effect of threonine on tyrosine metabolism of rats fed a low protein diet

Legal Events

Date Code Title Description
8125 Change of the main classification

Ipc: A61K 31/195

8126 Change of the secondary classification

Ipc: A61K 31/40

8127 New person/name/address of the applicant

Owner name: FRESENIUS AG, 6380 BAD HOMBURG, DE

D2 Grant after examination
8364 No opposition during term of opposition